Allergy and Immunology Service, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Histocompatibility and Cryopreservation Laboratory, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Eur Ann Allergy Clin Immunol. 2022 Sep;54(5):207-217. doi: 10.23822/EurAnnACI.1764-1489.193. Epub 2021 Mar 16.
Severe cutaneous adverse reactions (SCAR) are potentially fatal reactions. Genetic predisposition is involved in their pathogenesis related to drugs and ethnicities, however in a mixed population these relationships are still unknown. The aim of this study was to describe phenotypes, suspect drugs and HLA-alleles related to SCAR, identified by a systematized approach in a Brazilian case series. Patients who were diagnosed with SCAR between March 2011 and July 2019 at our university hospital were included. European Network for Drug Allergy (ENDA) questionnaire was used to collect clinical and laboratory data and algorithms for assessment of drug causality were applied. Socio-demographic variables included age, gender and skin color/ethnicity. Drug patch tests (DPT) and HLA-A, -B, -DRB1 typing were carried out. . A total of 74 patients were included: 36 (48.64%) with SJS/TEN, 32 (43.24%) DRESS/DIHS, 3 (4.05%) AGEP, 2 (2.70%) overlap(DRESS/SJS and DRESS/AGEP) and 1 (1.35%) GBFDE. The median age was31.5 years (IQR = 14-52.25), most were female (n = 44/59.46%) and brown (n = 38/51.35%). Anticonvulsants (n = 32/43.24%) were the largest group involved and antibiotics (n = 26/35.13%) were the second most common. Two patients with DRESS died during the acute phase. Positive DPT were shown only in anticonvulsant associated DRESS. HLA related to abacavir, allopurinol and carbamazepine were identified. A systematized approach allowed the phenotypic characterization of SCAR. The HLA-A31:01, B57:01 and B*58:01 alleles were identified, reinforcing the causality in SCAR by CBZ, ABC and ALLO in the Brazilian population.
严重皮肤不良反应(SCAR)是潜在致命的反应。遗传易感性与药物和种族有关,但在混合人群中,这些关系尚不清楚。本研究的目的是描述通过系统方法在巴西病例系列中识别的与 SCAR 相关的表型、可疑药物和 HLA 等位基因。纳入 2011 年 3 月至 2019 年 7 月在我院确诊为 SCAR 的患者。使用欧洲药物过敏网络(ENDA)问卷收集临床和实验室数据,并应用药物因果关系评估算法。社会人口学变量包括年龄、性别和肤色/种族。进行药物斑贴试验(DPT)和 HLA-A、-B、-DRB1 分型。共纳入 74 例患者:36 例(48.64%)为 SJS/TEN,32 例(43.24%)为 DRESS/DIHS,3 例(4.05%)为 AGEP,2 例(2.70%)为重叠(DRESS/SJS 和 DRESS/AGEP),1 例(1.35%)为 GBFDE。中位年龄为 31.5 岁(IQR = 14-52.25),大多数为女性(n = 44/59.46%)和棕色(n = 38/51.35%)。抗惊厥药(n = 32/43.24%)是涉及最多的药物,其次是抗生素(n = 26/35.13%)。两名 DRESS 患者在急性期死亡。仅在与抗惊厥药相关的 DRESS 中显示出阳性 DPT。鉴定出与 abacavir、别嘌醇和卡马西平相关的 HLA。采用系统方法对 SCAR 的表型特征进行了描述。鉴定出 HLA-A31:01、B57:01 和 B*58:01 等位基因,在巴西人群中强化了 CBZ、ABC 和 ALLO 引起 SCAR 的因果关系。